DISEASE INDICATIONS: Primary Biliary Cholangitis (PBC)

MANUFACTURER: Novartis

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Isturisa (osilodrostat) is a drug utilized in the cure of grown-up individuals affected by Cushing’s syndrome or for grown-ups with Cushing’s disease who are ineligible for surgery or did not have a positive response to surgery done previously.